Literature DB >> 3597710

Pituitary-thyroid axis in critical illness.

J Faber, C Kirkegaard, B Rasmussen, H Westh, M Busch-Sørensen, I W Jensen.   

Abstract

Severe nonthyroidal illness has been claimed to cause secondary hypothyroidism. We reevaluated this concept measuring serum free T4 and free T3 by an ultrafiltration method and serum TSH by an ultrasensitive technique (detection limit, and serum TSH by an ultrasensitive technique (detection limit, 0.05 mU/L). Forty-five critically ill patients suffering from hepatic coma (n = 10), terminal cancer (n = 9), stroke (n = 8), and respiratory insufficiency not treated (n = 7) and treated (n = 11) with dopamine were studied. The mortality rate was 80%. No patients received glucocorticoids, and only patients in the last group received dopamine. Serum total as well as free thyroid hormone index values were grossly reduced in the majority of the patients. The 34 patients not receiving dopamine in general had normal values of serum free T4 (32 of 34) and free T3 (31 of 34), measurable TSH (33 of 34), and detectable TSH responses to iv TRH (33 of 34). In contrast, the dopamine-treated patients had reduced serum free T4 and TSH levels compared to normal subjects (P less than 0.05), as well as reduced TSH responses to TRH (P less than 0.01). Serum free T4 and free T3 were below the normal range in 3 patients and 1 patient, respectively, and serum TSH was below the detection limit in 2 patients. We conclude that critically ill patients with nonthyroidal illness not receiving dopamine have normal pituitary-thyroid function, whereas dopamine induces some degree of secondary hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597710     DOI: 10.1210/jcem-65-2-315

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns?

Authors:  G Pittoni; G Gallioi; M Zanello; L Gianotti; M F Boghen; S Colombo; F Broglio; C Santoro; G Davià; M G Papini; S Destefanis; F Minuto; C Miola; E Ghigo
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

2.  Hormonal status and ICU-acquired paresis in critically ill patients.

Authors:  Tarek Sharshar; Sylvie Bastuji-Garin; Bernard De Jonghe; Robert D Stevens; Andrea Polito; Virginie Maxime; Pablo Rodriguez; Charles Cerf; Hervé Outin; Philippe Touraine; Kathleen Laborde
Journal:  Intensive Care Med       Date:  2010-03-24       Impact factor: 17.440

3.  Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone.

Authors:  Kelli K Ryckman; Cassandra N Spracklen; John M Dagle; Jeffrey C Murray
Journal:  J Pediatr Endocrinol Metab       Date:  2014-09       Impact factor: 1.634

4.  Simple evaluation of thyroid function.

Authors:  J P Kriss
Journal:  West J Med       Date:  1988-04

5.  Non-Thyroidal Illness Syndrome in Critically Ill Children: Prognostic Value and Impact of Nutritional Management.

Authors:  An Jacobs; Inge Derese; Sarah Vander Perre; Esther van Puffelen; Sören Verstraete; Lies Pauwels; Sascha Verbruggen; Pieter Wouters; Lies Langouche; Gonzalo Garcia Guerra; Koen Joosten; Ilse Vanhorebeek; Greet Van den Berghe
Journal:  Thyroid       Date:  2019-03-11       Impact factor: 6.568

6.  Assessment of thyroid function in intensive care unit patients by liquid chromatography tandem mass spectrometry methods.

Authors:  Kerry J Welsh; Brian R Stolze; Xiaolin Yu; Trisha R Podsiadlo; Lisa S Kim; Steven J Soldin
Journal:  Clin Biochem       Date:  2016-11-25       Impact factor: 3.281

7.  Development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake.

Authors:  H L Kristensen; S Vadstrup; N Knudsen; K Siersbaek-Nielsen
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

8.  Pituitary-hormone secretion by thyrotropinomas.

Authors:  Ferdinand Roelfsema; Simon Kok; Petra Kok; Alberto M Pereira; Nienke R Biermasz; Jan W Smit; Marijke Frolich; Daniel M Keenan; Johannes D Veldhuis; Johannes A Romijn
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

9.  Clinical analysis on alteration of thyroid hormones in the serum of patients with acute ischemic stroke.

Authors:  Yonghua Zhang; Michael A Meyer
Journal:  Stroke Res Treat       Date:  2010-08-09

Review 10.  Clinical use of sensitive assays for thyroid-stimulating hormone.

Authors:  P A Masters; R J Simons
Journal:  J Gen Intern Med       Date:  1996-02       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.